Physician

Stephen Legrande Vance, M.D.

According to 2025 Medicare claims, Stephen Vance, M.D. (NPI: 1821403247) practices micrographic dermatologic surgery in the Harrisonburg, VA market, with the plurality of this provider's patient population coming from Rockingham, VA. This provider's primary affiliated billing organization is SHENANDOAH DERMATOLOGY, P.C. (NPI: 1023484219; TIN: 47-4620471) and primary practice location at 24401-9504. Vance is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Vance's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,085 traditional Medicare patients, billed 4,237 HCPCS/CPT codes, and received $1,047,484 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,619 prescription claims across 988 beneficiaries totaling $14,824 in drug costs, led by Mupirocin (Mupirocin). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $126,886 to $1,047,484. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $11,749 and ending at $14,824. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$524K$1.0M2019 Medicare payment: $126,886 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $571,556 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $831,604 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $897,315 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $953,834 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,047,484 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019112553$126,886
20204532,508$571,556
20217023,329$831,604
20228103,491$897,315
20239273,728$953,834
20241,0854,237$1,047,484

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$60K$119K2015 Drug cost: $11,749 (USD; Tot_Drug_Cst)2016 Drug cost: $10,135 (USD; Tot_Drug_Cst)2017 Drug cost: $67,149 (USD; Tot_Drug_Cst)2018 Drug cost: $119,075 (USD; Tot_Drug_Cst)2019 Drug cost: $1,766 (USD; Tot_Drug_Cst)2020 Drug cost: $6,988 (USD; Tot_Drug_Cst)2021 Drug cost: $12,684 (USD; Tot_Drug_Cst)2022 Drug cost: $10,803 (USD; Tot_Drug_Cst)2023 Drug cost: $15,975 (USD; Tot_Drug_Cst)2024 Drug cost: $14,824 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201556146$11,749
201655139$10,135
201779305$67,149
201868206$119,075
20195378$1,766
2020339538$6,988
2021470721$12,684
2022576994$10,803
20237801,330$15,975
20249881,619$14,824

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks8331,016$453
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks399523$317
13132Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm259271$181
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more571947$67
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more220256$38

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MupirocinMupirocin67713,232$7,797
Doxycycline HyclateDoxycycline Hyclate8114,046$4,479
Gentamicin SulfateGentamicin Sulfate26561$1,486
CephalexinCephalexin46132$356
Tramadol HclTramadol Hcl3366$42

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Stephen Legrande Vance, M.D.?

Tedicare shows public-source Medicare data for Stephen Legrande Vance, M.D. (NPI 1821403247), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephen Legrande Vance, M.D. have ACO affiliation data?

Stephen Legrande Vance, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Stephen Legrande Vance, M.D.?

Stephen Legrande Vance, M.D. is linked to SHENANDOAH DERMATOLOGY, P.C. (billing NPI 1023484219) in the available physician profile data.

Does Stephen Legrande Vance, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.